Clinical Trial

Fibrine Clot-augmented Repair of Longitudinal Meniscus Tears

Study acronym: FCAR
Recruiting
View on ClinicalTrials.gov →
Summary
Longitudinal meniscal tears are a type of meniscal injury characterized by a displaced fragment of the meniscus that flips over into the joint, often resembling a buckle or handle. These tears typically occur in the medial meniscus and are often associated with traumatic knee injuries, particularly in athletes. The displaced meniscal fragment can cause mechanical symptoms such as locking, clicking, or catching of the knee, as well as pain and swelling. If not properly treated, buckle-handle meniscal tears can lead to further complications, including chronic knee instability, increased risk of osteoarthritis, and persistent joint pain.Repairing a longitudinal meniscal tear offers several advantages over partial meniscectomy, particularly in preserving knee function and preventing long-term complications. Meniscal repair aims to restore the integrity of the meniscus, which plays a crucial role in load distribution, shock absorption, and joint stability. Utilizing a fibrin clot during the repair of a buckle-handle meniscal tear can enhance the healing process and improve surgical outcomes. Fibrin clots act as a biological scaffold, promoting tissue regeneration by providing a matrix that facilitates cellular migration and proliferation. The purpose of this study was to compare longitudinal meniscal tear repair reinforced with fibrin clot with routine end-to-end repair in a prospective randomized controlled trial.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-06.
Trial Details
NCT Number NCT06541756
Lead Sponsor Ankara City Hospital Bilkent
Collaborators: Ankara Etlik City Hospital
Conditions Meniscus Tear, Meniscus Lesion, Fibrin Blood Clot, Knee Injuries
Enrollment 120 participants
Start Date 2024-07-25
Primary Completion 2028-07-31 (estimated)
Study Completion 2029-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-02